Hit enter to search or ESC to close
IPO Details Purpose of IPO: Hengrui Pharma aims to raise up to HK$9.89 billion (US$1.27 billion) through its Hong Kong listing. The proceeds are allocated as follows: Approximately 45% for funding clinical studies of...
